These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2239 related items for PubMed ID: 25227018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD.
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J, Thureau S, Dubray B, Modzelewski R, Thiberville L, Gardin I, Vera P.
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H, Wang R, Zhao F, Zhu K, Jiang S, Zhao W, Feng R.
    Acta Radiol; 2011 Jul 01; 52(6):646-50. PubMed ID: 21508201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
    Kurtipek E, Çayci M, Düzgün N, Esme H, Terzi Y, Bakdik S, Aygün MS, Unlü Y, Burnik C, Bekci TT.
    Clin Nucl Med; 2015 Jun 01; 40(6):459-63. PubMed ID: 25742234
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H.
    Nucl Med Commun; 2012 Jun 01; 33(6):613-20. PubMed ID: 22407127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
    Sahiner I, Atasever T, Akdemir UO, Ozturk C, Memis L.
    Rev Esp Med Nucl Imagen Mol; 2013 Jun 01; 32(6):357-63. PubMed ID: 23747221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 112.